id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-V-1596-0003,FDA,FDA-2013-V-1596,Variance Approval from FDA CDRH to Duality,Other,Approval for Variance (VRA),2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,,2014-02-26T16:46:40Z,,0,0,09000064815c55f2
FDA-2013-V-1596-0001,FDA,FDA-2013-V-1596,Duality- Application for Variance,Other,Application for Variance (VAR),2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T18:19:11Z,,0,0,09000064814b23ab
FDA-2013-V-1596-0002,FDA,FDA-2013-V-1596,Acknowledgement Letter to Duality,Other,Acknowledgement Letter/Receipt,2013-12-31T05:00:00Z,2013,12,2013-12-31T05:00:00Z,,2013-12-31T18:19:19Z,,0,0,09000064814b34bb